Roquilly, Antoine http://orcid.org/0000-0002-1029-6242
Francois, Bruno
Huet, Olivier
Launey, Yoann
Lasocki, Sigismond
Weiss, Emmanuel
Petrier, Melanie
Hourmant, Yannick
Bouras, Marwan
Lakhal, Karim
Le Bel, Cecilia
Flattres Duchaussoy, Delphine
Fernández-Barat, Laia
Ceccato, Adrian
Flet, Laurent
Jobert, Alexandra
Poschmann, Jeremie
Sebille, Veronique
Feuillet, Fanny
Koulenti, Despoina
Torres, Antoni
Grillot, Nicolas
Asehnoune, Karim
Bourdiol, Alexandre
Demeure dit latte, Dominique
Armaganidis, Apostolos
Nesseler, Nicolas
Seguin, Philippe
,
Funding for this research was provided by:
H2020 Excellent Science (847782)
Article History
Received: 1 February 2023
Accepted: 31 March 2023
First Online: 18 April 2023
Declarations
:
: AR reports receiving grants and consulting fees from Merck and bioMerieux. Other authors declare that they have no conflicts of interest involving the work under consideration for publication. No compensation was received for this study. AT has conflicts of interest with BioMerieux, Pfizer, and MSD (advisory boards or lectures).
: AR had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. FF conducted and was responsible for data analysis.
: See electronic supplementary material 6.
: Filipe Froes (Hospital Pulido Valente, Portugal), Marylaure Gavard (Grenoble University Hospital, France), Bruno Giraudeau (University of Tours, France), Marc Leone (AP/HM, France) and Pedro Póvoa (São Francisco Xavier Hospital, Portugal).